Research Site

Whitchurch CF14 2TL

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Hormone-Sensitive Prostate Cancer

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency — Running, not enrolling